Cidofovir for cytomegalovirus (CMV) antigenemia after allogeneic stem cell transplantation.

被引：0
|
作者：
Soligo, D [1 ]
Tagliaferri, E [1 ]
Barraco, F [1 ]
Lambertenghi, D [1 ]
Della Volpe, A [1 ]
Deliliers, GL [1 ]
机构：
[1] Osped Maggiore, IRCCS, Ctr Trapianti Midollo, Milan, Italy
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4461
引用
收藏
页码：339B / 339B
页数：1
相关论文
共 50 条
  • [21] Quantitative analysis of CMV DNA in children after allogeneic haematopoietic stem cell transplantation.
    Mellgren, Karin
    Kullberg-Lindh, Carola
    Lindh, Magnus
    Friman, Vanda
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 69 - 69
  • [22] Valganciclovir in the prevention of cytomegalovirus following allogeneic stem cell transplantation.
    Magalhaes-Silverma, Margarida
    Parrott, Karen
    Carter, Thomas
    Leopold, Christina
    Raymond, Hohl
    Roger, Gingrich
    BLOOD, 2006, 108 (11) : 807A - 807A
  • [23] Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening
    Takehiko Mori
    Taku Kikuchi
    Miki Koh
    Yuya Koda
    Rie Yamazaki
    Masatoshi Sakurai
    Yohei Tomita
    Yoko Ozawa
    Sumiko Kohashi
    Ryohei Abe
    Masuho Saburi
    Jun Kato
    Bone Marrow Transplantation, 2021, 56 : 1266 - 1271
  • [24] Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening
    Mori, Takehiko
    Kikuchi, Taku
    Koh, Miki
    Koda, Yuya
    Yamazaki, Rie
    Sakurai, Masatoshi
    Tomita, Yohei
    Ozawa, Yoko
    Kohashi, Sumiko
    Abe, Ryohei
    Saburi, Masuho
    Kato, Jun
    BONE MARROW TRANSPLANTATION, 2021, 56 (06) : 1266 - 1271
  • [25] Risk factors and outcomes of CMV antigenemia after stem cell transplantation
    Naini, MM
    Ghavamzadeh, A
    Iravani, M
    Jahani, M
    Bahar, B
    Mousavi, A
    Natanzi, HG
    Gholibeikian, S
    BONE MARROW TRANSPLANTATION, 2003, 31 : S96 - S96
  • [26] Risk factors and outcomes of CMV antigenemia in children with allogeneic haematopoietic stem cell transplantation
    Cho, B
    Jeong, DC
    Chung, NG
    Park, YS
    Jang, PS
    Kim, HK
    BONE MARROW TRANSPLANTATION, 2005, 35 : S347 - S347
  • [27] Cidofovir (CDF) for the treatment of EBV-infection in allogeneic stem cell transplantation.
    Ullmann, J
    Ledderose, G
    Jaeger, G
    Kolb, HJ
    BLOOD, 2000, 96 (11) : 192A - 192A
  • [28] Antibacterial antibiotic exposures and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
    Zhang, Shijia
    Shanley, Ryan
    Rashidi, Armin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Cytomegalovirus pp65 antigenemia-guided management of cytomegalovirus infection and diseases in allogeneic stem cells transplantation.
    Dong, L
    Hu, LD
    Pian, HY
    Qin, MQ
    Yu, ZY
    Lu, SJ
    Jia, SQ
    Chen, H
    Jiang, M
    BLOOD, 2000, 96 (11) : 338B - 338B
  • [30] CYTOMEGALOVIRUS (CMV) REACTIVATION AND RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT
    Ramanathan, M.
    Cerny, J.
    Shanahan, L.
    Kroll, A.
    Nath, R.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S467 - S468
12345